AdvisorShares Psychedelics ETF Rating $23.54 -0.50 (-2.08%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.64Holdings in PSIL have an aggregate rating of Moderate Buy based on 200 analyst ratings issued in the past year covering 19 companies (85.1% of the portfolio).PSIL Aggregate Price Target$23.54High Prediction$23.54Average Prediction$23.54Low Prediction$23.54Holdings in PSIL have an aggregate price target of $23.54 and a range of $23.54 to $23.54 covering 19 companies (85.1% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell2 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 PSIL Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.27%ATAIAtai Beckley$7.18+0.1%3.1989 of 5 stars2.31$11.38 58.5%16Analyst Revision11.83%DFTXDefinium Therapeutics$43.17+0.6%3.0383 of 5 stars3.00$51.15 18.5%17Analyst ForecastGap Up10.43%CMPSCompass Pathways$11.26-3.8%3.1085 of 5 stars2.94$24.15 114.5%16News CoveragePositive NewsUpcoming Earnings6.18%NRXPNRx Pharmaceuticals$3.75-8.8%2.6577 of 5 stars2.50$38.25 920.0%65.30%RLMDRelmada Therapeutics$5.18-0.4%2.4161 of 5 stars2.75$12.00 131.7%8News CoveragePositive News4.85%GHRSGH Research$27.28-1.3%2.5904 of 5 stars2.64$40.38 48.0%114.46%ANROAlto Neuroscience$26.72-0.5%2.0684 of 5 stars2.55$35.25 31.9%11News CoverageAnalyst Downgrade4.38%NBIXNeurocrine Biosciences$175.77+0.9%4.6822 of 5 stars2.96$194.05 10.4%23News CoveragePositive NewsUpcoming EarningsAnalyst Forecast4.34%ABBVAbbVie$259.10+0.8%4.3525 of 5 stars2.84$268.10 3.5%25Trending NewsUpcoming EarningsAnalyst Forecast4.18%ALKSAlkermes$52.89-0.2%2.218 of 5 stars2.72$52.50 -0.7%18News CoveragePositive NewsUpcoming Earnings3.71%JNJJohnson & Johnson$263.43+1.6%4.2872 of 5 stars2.80$265.30 0.7%25Trending News2.94%SUPNSupernus Pharmaceuticals$46.20-2.1%4.0405 of 5 stars2.43$62.83 36.0%7News CoveragePositive NewsAnalyst DowngradeShort Interest Decrease2.92%STIMNeuronetics$1.73-8.0%3.5512 of 5 stars2.50$4.00 131.2%4Analyst Forecast1.97%NEUPNeuphoria Therapeutics$3.64-7.1%2.9086 of 5 stars2.00$21.00 476.9%4News CoverageAnalyst Upgrade0.95%KTTAPasithea Therapeutics$0.46-5.2%3.4737 of 5 stars2.67$3.00 559.3%3Gap Down0.81%PBMPsyence Biomedical$2.95+4.6%1.8229 of 5 stars1.001Positive NewsGap Up0.80%SILOSilo Pharma$4.47+0.2%0.5347 of 5 stars1.001Short Interest Increase0.42%IXHLIncannex Healthcare$2.95-6.6%2.1844 of 5 stars2.00$18.00 510.2%2News CoverageShort Interest Increase0.38%IGCIGC Pharma$0.26-0.4%2.3466 of 5 stars2.50$5.50 1,983.3%2 This page (NYSEARCA:PSIL) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
